See more : Steinhoff International Holdings N.V. (SNH.DE) Income Statement Analysis – Financial Results
Complete financial analysis of CARBIOTIX AB (CRBX.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CARBIOTIX AB, a leading company in the Specialty Business Services industry within the Industrials sector.
You may be interested
- Atlantic Union Bankshares Corporation (AUB) Income Statement Analysis – Financial Results
- Gaensel Energy Group, Inc. (GEGR) Income Statement Analysis – Financial Results
- Oriental Trimex Limited (ORIENTALTL.NS) Income Statement Analysis – Financial Results
- Ryde Group Ltd. (RYDE) Income Statement Analysis – Financial Results
- LS 1x Facebook Tracker ETP (FB1.L) Income Statement Analysis – Financial Results
CARBIOTIX AB (CRBX.ST)
About CARBIOTIX AB
Carbiotix AB is a pre-clinical stage therapeutics company. It engages in the provision of products and medicines that produce good bacteria from intestine to counter metabolic and chronic diseases. The company was founded in 2014 and is headquartered in Lund, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.47M | 407.59K | 411.27K | 129.82K | 188.43K | 2.78M | 2.33M |
| Cost of Revenue | -1.99M | -1.76M | -2.18M | -3.45M | -2.98M | -1.35M | -248.47K |
| Gross Profit | 3.45M | 2.17M | 2.59M | 3.58M | 3.17M | 4.13M | 2.58M |
| Gross Profit Ratio | 235.45% | 533.01% | 629.48% | 2,755.62% | 1,681.06% | 148.42% | 110.66% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 5.52M | 4.33M | 4.53M | 3.21M | 2.21M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 16.76M | 0.00 | 5.52M | 4.33M | 4.53M | 3.21M | 2.21M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 16.76M | 14.42M | 13.06M | 9.56M | 8.56M | 6.13M | 3.31M |
| Cost & Expenses | 14.77M | 12.66M | 10.88M | 6.11M | 5.58M | 4.78M | 3.06M |
| Interest Income | 193.00 | 0.00 | 0.00 | 0.00 | 1.40K | 0.00 | 0.00 |
| Interest Expense | 174.62K | 971.00 | 8.30K | 5.97K | 13.52K | 24.03K | 21.98K |
| Depreciation & Amortization | 187.10K | 108.34K | 51.33K | 206.30K | 171.86K | 161.14K | 52.52K |
| EBITDA | -13.12M | -12.14M | -10.42M | -5.98M | -5.39M | -1.99M | -733.04K |
| EBITDA Ratio | -895.07% | -2,979.02% | -2,532.69% | -4,604.66% | -2,862.91% | -71.64% | -31.45% |
| Operating Income | -13.30M | -12.25M | -10.47M | -5.98M | -5.40M | -1.99M | -733.04K |
| Operating Income Ratio | -907.85% | -3,005.60% | -2,545.17% | -4,604.66% | -2,863.65% | -71.64% | -31.45% |
| Total Other Income/Expenses | -174.43K | -971.00 | -8.30K | -5.97K | -12.12K | -24.03K | -21.98K |
| Income Before Tax | -13.48M | -12.25M | -10.48M | -5.98M | -5.41M | -2.02M | -755.02K |
| Income Before Tax Ratio | -919.76% | -3,005.84% | -2,547.19% | -4,609.26% | -2,870.08% | -72.50% | -32.39% |
| Income Tax Expense | 0.00 | -111.16K | 13.91K | 802.65K | -5.71K | -161.14K | -52.52K |
| Net Income | -13.48M | -12.25M | -10.48M | -5.98M | -5.41M | -2.02M | -755.02K |
| Net Income Ratio | -919.76% | -3,005.84% | -2,547.19% | -4,609.26% | -2,870.08% | -72.50% | -32.39% |
| EPS | -0.28 | -36.16 | -35.52 | -22.56 | -26.33 | -9.80 | -3.68 |
| EPS Diluted | -0.28 | -36.16 | -35.52 | -22.56 | -26.33 | -9.80 | -3.68 |
| Weighted Avg Shares Out | 48.94M | 338.79K | 294.95K | 265.19K | 205.41K | 206.06K | 205.41K |
| Weighted Avg Shares Out (Dil) | 48.94M | 338.79K | 294.95K | 265.19K | 205.41K | 206.06K | 205.41K |
No news found for: CRBX.ST
Source: https://incomestatements.info
Category: Stock Reports